Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Highly Potent 17╬▓-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy.

Siebenbuerger L, Hernandez-Olmos V, Abdelsamie AS, Frotscher M, van Koppen CJ, Marchais-Oberwinkler S, Scheuer C, Laschke MW, Menger MD, Boerger C, Hartmann RW.

J Med Chem. 2018 Nov 27. doi: 10.1021/acs.jmedchem.8b01373. [Epub ahead of print]

PMID:
30480443
2.

Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing's Disease.

Emmerich J, van Koppen CJ, Burkhart JL, Hu Q, Siebenb├╝rger L, Boerger C, Scheuer C, Laschke MW, Menger MD, Hartmann RW.

J Med Chem. 2017 Jun 22;60(12):5086-5098. doi: 10.1021/acs.jmedchem.7b00437. Epub 2017 Jun 9.

PMID:
28570067
3.

Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians.

Ott G, Reichmann D, Boerger C, Cascorbi I, Bittner F, Mendel RR, Kunze T, Clement B, Havemeyer A.

Drug Metab Dispos. 2014 Apr;42(4):718-25. doi: 10.1124/dmd.113.055202. Epub 2014 Jan 14.

PMID:
24423752
4.

Plastic ingestion by planktivorous fishes in the North Pacific Central Gyre.

Boerger CM, Lattin GL, Moore SL, Moore CJ.

Mar Pollut Bull. 2010 Dec;60(12):2275-8. doi: 10.1016/j.marpolbul.2010.08.007. Epub 2010 Nov 9.

PMID:
21067782

Supplemental Content

Loading ...
Support Center